We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 1,428

The medical devices market in China
  • Frost Brown Todd LLC
  • China
  • October 29 2014

According to the U.S. Department of Commerce, China is now the world's second largest market for medical equipment. According to the Hong Kong Trade

依赖遗传资源申请的 PCT 现状及中国专利法的相关规定
  • Kangxin Partners PC
  • China, Global
  • October 24 2014

作为生物多样性最丰富的国家之一我国于 1992 年 6 月 11 日签署了生物多样性公约随后我国人大常委会于 1992 年 11 月 7 日批准加入该公约1993 年 1 月 5 日正式缴存加入书是最早正式加入该公约的国家之一生物多样性公约于 1993 年 12 月 20 日生效

Further opening-up of policies on wholly-foreign-owned medical institutions - seven pilot provinces (cities) in China following Shanghai FTZ's step
  • Hogan Lovells
  • China
  • October 27 2014

As the opening-up policy on health services in China pushes forward, the Chinese government further sets up seven pilot areas where qualified foreign

China aims to tighten supervision over clinical studies
  • Ropes & Gray LLP
  • China
  • October 31 2014

China's health authority, the National Health and Family Planning Commission ("NHFPC"), recently released the Administrative Measures for the

GSK bribery conviction signals increased risks in China
  • Fenwick & West LLP
  • China, USA
  • October 21 2014

On September 19, 2014, a Chinese court found pharmaceutical giant GlaxoSmithKline PLC (GSK) guilty of bribing doctors and hospitals in order to

  • CCPIT Patent & Trademark Law Office
  • China
  • November 5 2014

在准备递交专利申请时需要满足充分公开的要求这一点在中国尤为重要有数据表明在 2012 年前一旦专利申请在中国因为公开不充分而被驳回的话只有不到 5 成的案件能 在复审阶段逆转局面

China healthcare: easing of market access barriers to encourage private investment
  • Norton Rose Fulbright LLP
  • China
  • December 24 2014

The Chinese government recently announced guidelines for the easing of market access barriers in a number of key sectors. The medical and healthcare

China healthcare: government incentives for foreign investors in for-profit senior care
  • Norton Rose Fulbright LLP
  • China
  • December 30 2014

In 2012, China's population aged 60 and over was 194 million. By 2025, this population is expected to reach 300 million. In response to growing

Developments in China's healthcare sector
  • Deacons
  • China
  • December 29 2014

The Chinese government has recently issued two new policy documents on foreign investment in China's healthcare sector: The Circular regarding

China’s “golden age” investment opportunity
  • Frost Brown Todd LLC
  • China
  • January 23 2015

China's healthcare market is expected to grow from $357 billion in 2011 to $1 trillion by 2020 according to McKinsey & Company. This makes China the